An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc)

NCT05626751 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

174

Enrollment

INDUSTRY

Sponsor class

Stopped The study was not stopped due to safety reasons

Conditions

Diffuse Cutaneous Systemic Sclerosis
Sclerosis, Systemic

Interventions

DRUG: HZN-825

Sponsor

Amgen